Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ingeborg Wildfang"'
Publikováno v:
Springer Reference Medizin ISBN: 9783662467640
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df1b195833296ba952dcb227556c69ca
https://doi.org/10.1007/978-3-662-46764-0_86-1
https://doi.org/10.1007/978-3-662-46764-0_86-1
Autor:
Hans Christiansen, S.E. Schild, A. Meier, Dirk Rades, Fabian B. Fahlbusch, Andreas Meyer, Stefan Janssen, Christoph Henkenberens, Ingeborg Wildfang
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 194(9)
To assess the outcome of breast cancer patients with local recurrence who underwent partial external beam re-irradiation (re-RT) either as part of a second breast-conserving therapy or following mastectomy. Between 03/2004 and 10/2016, 83 breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2251166583b3abee31b22970e678547e
https://pubmed.ncbi.nlm.nih.gov/29796694
https://pubmed.ncbi.nlm.nih.gov/29796694
Autor:
Hiba Basic, Volker Rudat, Johann H. Karstens, Dirk Rades, Irenaeus A. Adamietz, Ingeborg Wildfang, Amira Bajrovic, Juergen Dunst, Steven E. Schild, Thekla Meyners, Katja Freundt
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 80:1492-1497
Radiotherapy alone is the most common treatment for metastatic spinal cord compression (MSCC) from relatively radioresistant tumors such as renal cell carcinoma, colorectal cancer, and malignant melanoma. However, the results of the "standard" regime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0107f05d7397fcf157c6c7fbe6cb9469
https://doi.org/10.1016/j.ijrobp.2010.04.026
https://doi.org/10.1016/j.ijrobp.2010.04.026
Autor:
Lukas J.A. Stalpers, Nermina Obralic, Peter Hoskin, Rita Engenhart-Cabilic, Jochen Walz, Ingeborg Wildfang, Steven E. Schild, Rainer Schulte, Theo Veninga, Dirk Rades
Publikováno v:
European urology, 49(5), 846-52; discussion 852. Elsevier
For MSCC treatment, a short treatment time is desirable, especially if survival prognosis is poor. Survival depends on the primary tumor, extent of disease, performance status, ambulatory status, and the number of involved vertebrae. These factors ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88a80f9ad6919da9a38d43c17aa5a84a
https://doi.org/10.1016/j.eururo.2005.11.004
https://doi.org/10.1016/j.eururo.2005.11.004
Autor:
Ingeborg Wildfang, Rita Engenhart-Cabilic, Winfried Alberti, Volker Rudat, Amira Bajrovic, Rainer Schulte, Dirk Rades, Johann H. Karstens, Lukas J.A. Stalpers, Silke Tribius, Theo Veninga, Juergen Dunst, Fabian Fehlauer, Steven E. Schild, Hiba Basic, Peter Hoskin
Publikováno v:
Journal of clinical oncology, 24(21), 3388-3393. American Society of Clinical Oncology
Purpose To evaluate potential prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression (MSCC). Patients and Methods The following potential prognostic factors were investigated retrospectively in 1,85
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b0b9d475193bd59663d67e9545363ac
https://doi.org/10.1200/jco.2005.05.0542
https://doi.org/10.1200/jco.2005.05.0542
Autor:
Dirk Rades, B. Dietl, Christof Hofele, Ingeborg Wildfang, R. Dammer, Johann H. Karstens, Rudat, André Eckardt
Publikováno v:
Mund-, Kiefer- und Gesichtschirurgie. 6:117-121
PURPOSE The purpose of simultaneous chemoradiotherapy is to increase local-regional control and to decrease the incidence of distant metastases. Regimens containing cisplatin/5-FU chemotherapy are widely accepted as standard treatment in advanced hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5460573c414d7d40cb94e6d027fc2827
https://doi.org/10.1007/s10006-002-0370-y
https://doi.org/10.1007/s10006-002-0370-y
Autor:
Dirk Rades, Grit Kühnel, Anne Rose Börner, Johann H. Karstens, Ingeborg Wildfang, Wolfram H. Knapp
Publikováno v:
Strahlentherapie und Onkologie. 177:525-529
Bei Patienten mit unbekanntem Primartumor wird zwischen einem lokal begrenzten und einem disseminierten Stadium unterschieden. Bei lokal begrenzter Manifestation betragt die mediane Uberlebenszeit 20, bei Disseminierung 7 Monate. Nach diagnostischen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c57541dd6a585bde6cd4c01441f52fa
https://doi.org/10.1007/pl00002363
https://doi.org/10.1007/pl00002363
Simultane Radiochemotherapie mit Taxol/Carboplatin bei fortgeschrittenen operablen Kopf-Hals-Tumoren
Publikováno v:
Strahlentherapie und Onkologie. 175:11-13
Die simultane Radiochemotherapie hat das Ziel, die lokoregionare Tumorkontrolle zu erhohen und die Rate an Fernmetastasen zu senken. Therapieregime, die Cisplatin/5-FU enthalten, sind allgemein als Standardtherapie bei fortgeschrittenen Kopf-Hals-Kar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6f3e92d026a9f95d5152593e36c25b7
https://doi.org/10.1007/bf03215921
https://doi.org/10.1007/bf03215921
Autor:
Matthias Altmayer, Axel Haverich, P Macchiarini, Michael Hardin, Ingeborg Wildfang, Thorsten Walles, Karl Schulze, Tetsuhiko Go
Publikováno v:
The Annals of thoracic surgery. 82(6)
Background We present our perioperative management of operable nonsmall-cell lung cancer invading the tracheobronchial bifurcation and the results obtained. Methods Fifty consecutive patients undergoing carinal surgery with radical lymphadenectomy ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::206786a9af5dc0805cf86890aa4e5903
https://pubmed.ncbi.nlm.nih.gov/17126096
https://pubmed.ncbi.nlm.nih.gov/17126096
Autor:
Dirk Rades, Jochen Dahm-Daphi, Lukas J.A. Stalpers, Theo Veninga, Roja Bahrehmand, Ingeborg Wildfang, Nermina Obralic, Rita Engenhart-Cabilic, Rainer Schulte, Steven E. Schild, Philip Poortmans, Peter Hoskin
Publikováno v:
International journal of radiation oncology, biology, physics, 64(5), 1452-1457. Elsevier Inc.
Purpose: To investigate the suitability of short-course radiotherapy (RT) for spinal cord compression (SCC) in myeloma patients. Methods and Materials: Data for 172 myeloma patients irradiated between January 1994 and December 2004 for SCC were retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a5c16987cb41bb81530639a8df8f09
https://pure.amc.nl/en/publications/shortcourse-radiotherapy-is-not-optimal-for-spinal-cord-compression-due-to-myeloma(87b74040-593b-4f63-ab04-132b6015e2e6).html
https://pure.amc.nl/en/publications/shortcourse-radiotherapy-is-not-optimal-for-spinal-cord-compression-due-to-myeloma(87b74040-593b-4f63-ab04-132b6015e2e6).html